Archive: 16/05/2018
New study provides rationale for use of a multi-target anticancer drug in patients with malignant pleural mesothelioma
The multi-target small molecule anticancer drug nintedanib shows promising effectiveness in stopping the growth of human malignant pleural mesothelioma, a fatal thoracic tumor, in preclinical models, according to a new study ...
May 16, 2018